Drug intelligence / Profile preview

cefprozil

Development stage
Approved
Lead developer
Bristol Myers Squibb
Modality
Small Molecules
Administration
Oral
01

Overview

Cefprozil is a semisynthetic, second-generation cephalosporin antibiotic used to treat a variety of bacterial infections, including pharyngitis, tonsillitis, otitis media (middle ear infection), sinusitis, bronchitis, and skin or soft tissue infections. It acts by binding to specific penicillin-binding proteins (PBPs) inside the bacterial cell wall and inhibiting the final stage of cell wall synthesis. This leads to cell lysis mediated by autolytic enzymes within the bacteria. Cefprozil is administered orally as tablets or suspension and is effective against a broad range of gram-positive and some gram-negative bacteria[1][2][3][4][5][6]. It does not work for viral infections such as colds or flu.

Brand names
Cefzil
Other names
cefprozil (E)-isomerE-cefproziltrans-cefprozil
02

Targets

PBP2B (Penicillin-binding protein 2B)PBP2x (Penicillin-binding protein 2x)PBP1A (Penicillin-binding protein 1A)

Beyond the preview

Go deeper on cefprozil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cefprozil.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call